Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.
Latest website image capture
Clouds background image

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T11:41:44.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:54:12.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Updated site revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:12:26.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 tag and removed the previous government-funding/operating-status notices, while core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-11T02:19:33.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Page updates include a government funding lapse notice indicating NIH Clinical Center status and a Revision: v3.4.1 (replacing v3.4.0); to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:22:51.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a glossary toggle and new footer metadata labels (Results Submitted, Last Update Submitted that Met QC Criteria) and a revision indicator (Revision: v3.4.0). Removed older labels (No Results Posted, Last Update Submitted that met QC Criteria, No FEAR Act data) and the previous revision (v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-27T23:58:50.000Z thumbnail image

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.